Young Ian, Dunning James, Mourad Firas, Escaloni James, Bliton Paul, Fernández-de-Las-Peñas César
Department of Physical Therapy, Tybee Wellness & Osteopractic, Tybee Island, USA.
Department of Physical Therapy, American Academy of Manipulative Therapy Fellowship in Orthopaedic Manual Physical Therapy, Montgomery, AL, USA.
Physiother Theory Pract. 2025 Jan 10:1-9. doi: 10.1080/09593985.2025.2450090.
Currently, there is conflicting clinimetric data on the patient-rated tennis elbow evaluation (PRTEE) and a paucity of evidence regarding the reliability, validity, and responsiveness of the numeric pain rating scale (NPRS), and tennis elbow function scale (TEFS) in patients with lateral elbow tendinopathy.
Perform a comprehensive clinimetric analysis of the NPRS, PRTEE, and TEFS in a sample of patients ( = 143) with lateral elbow tendinopathy.
Establish the reliability, construct validity, responsiveness, meaningful clinically important difference (MCID), and minimal detectable change (MDC) values for the NPRS, PRTEE, and TEFS at the 3-month follow-up.
The NPRS [intraclass correlation coefficient (ICC): 0.54, 95% confidence interval (CI): 0.17-0.78], PRTEE (ICC: 0.62, 95% CI: 0.21-0.86), and the TEFS (ICC: 0.71, 95% CI: 0.14-0.90) exhibited moderate reliability. All three outcomes exhibited excellent responsiveness [NPRS: area under the curve (AUC): 0.94, 95% CI: 0.89-0.98]; PRTEE: (AUC: 0.96, 95% CI 0.93-0.99); TEFS: (AUC: 0.95, 95% CI: 0.91-0.98). The MCID and MDC were 2.3 and 1.4 for the NPRS, 14.8 and 9.7 for the PRTEE, and 7.5 and 5.7 for the TEFS, respectively. All three patients reported outcome measures also demonstrated strong construct validity (Pearson's r from 0.71 to 0.83, < .001).
The NPRS, PRTEE, and TEFS are clinimetrically sound patient reported outcome measures for patients with lateral elbow tendinopathy at a 3-month follow-up.
REGISTRATION AT CLINICALTRIALS.GOV: NCT03167710.
目前,关于患者自评网球肘评估(PRTEE)存在相互矛盾的临床测量数据,且关于数字疼痛评分量表(NPRS)、网球肘功能量表(TEFS)在外侧肘肌腱病患者中的可靠性、有效性和反应性的证据不足。
对143例外侧肘肌腱病患者样本中的NPRS、PRTEE和TEFS进行全面的临床测量分析。
确定3个月随访时NPRS、PRTEE和TEFS的可靠性、结构效度、反应性、有临床意义的重要差异(MCID)和最小可检测变化(MDC)值。
NPRS[组内相关系数(ICC):0.54,95%置信区间(CI):0.17 - 0.78]、PRTEE(ICC:0.62,95%CI:0.21 - 0.86)和TEFS(ICC:0.71,95%CI:0.14 - 0.90)表现出中等可靠性。所有三项结果均表现出出色的反应性[NPRS:曲线下面积(AUC):0.94,95%CI:0.89 - 0.98];PRTEE:(AUC:0.96,95%CI 0.93 - 0.99);TEFS:(AUC:0.95,95%CI:0.91 - 0.98)。NPRS的MCID和MDC分别为2.3和1.4,PRTEE为14.8和9.7,TEFS为7.5和5.7。所有三项患者报告的结局指标也显示出很强的结构效度(Pearson相关系数r为0.71至0.83,P <.001)。
在3个月随访时,NPRS、PRTEE和TEFS是外侧肘肌腱病患者临床上合理的患者报告结局指标。
在ClinicalTrials.gov注册:NCT03167710。